Li Zhou
- Cancer Research top 2%
- Immunology top 5%
- interferon and immune responses 10
- Immune Cell Function and Interaction 8
- Virology top 5%
- HIV Research and Treatment 15
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 9
- RNA modifications and cancer 8
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 12
-
- Autophagy in Disease and Therapy 16
- Herpesvirus Infections and Treatments 10
- Co-authors
- Canhua HuangEdouard C. NiceZhao HuangZhe ZhangYunlong LeiLu ZhangNitin K. SaksenaYuanyuan Zhang
- Cited by
- Cancer ResearchImmunologyVirology
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Li Zhou
137 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Cancer Research 887
- Immunology 775
- Virology 165
- Molecular Biology 2.1k
- Infectious Diseases 435
Countries citing papers authored by Li Zhou
This map shows the geographic impact of Li Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Zhou more than expected).
Fields of papers citing papers by Li Zhou
This network shows the impact of papers produced by Li Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Zhou. The network helps show where Li Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Li Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 11 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 27 | |
| 10 | 2023 | 32 | |
| 11 | 2022 | 5 | |
| 12 | 2022 | 14 | |
| 13 | 2021 | 5 | |
| 14 | 2021 | 2 | |
| 15 | 2020 | 92 | |
| 16 | 2020 | 7 | |
| 17 | 2018 | 8 | |
| 18 | 2016 | 21 | |
| 19 | 2010 | 129 | |
| 20 | 2009 | 240 |
About Li Zhou
Li Zhou is a scholar working on Virology, Cancer Research and Immunology, having authored 145 papers that have together received 4.2k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (16 papers), HIV Research and Treatment (15 papers), SARS-CoV-2 and COVID-19 Research (12 papers), interferon and immune responses (10 papers), Herpesvirus Infections and Treatments (10 papers), Epigenetics and DNA Methylation (9 papers), Immune Cell Function and Interaction (8 papers) and RNA modifications and cancer (8 papers). The work is most often cited by research in Cancer Research (887 citations), Immunology (775 citations) and Virology (165 citations). Li Zhou has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Canhua Huang, Edouard C. Nice, Zhao Huang, Zhe Zhang, Yunlong Lei, Lu Zhang, Nitin K. Saksena, Yuanyuan Zhang, Jingwen Jiang and Man Wang. Their work appears in journals such as PLoS ONE, Frontiers in Immunology, Nature Communications, Antioxidants and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.